DNAPrint Genomics Company Top Insiders

DNAPrint Genomics Management Team Effectiveness

The company has return on total asset (ROA) of (1.05) % which means that it has lost $1.05 on every $100 spent on assets. This is way below average. DNAPrint Genomics' management efficiency ratios could be used to measure how well DNAPrint Genomics manages its routine affairs as well as how well it operates its assets and liabilities. The DNAPrint Genomics' current Return On Equity is estimated to increase to 4.02, while Return On Tangible Assets are projected to decrease to (1.16). At this time, DNAPrint Genomics' Other Current Assets are most likely to increase significantly in the upcoming years. The DNAPrint Genomics' current Total Current Assets is estimated to increase to about 10.6 M, while Return On Tangible Assets are projected to decrease to (1.16). The current Net Loss is estimated to decrease to about (11.7 M)

DNAPrint Genomics Workforce Comparison

DNAPrint Genomics Profit Margins

The company has Profit Margin (PM) of (2.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (7.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.31.

DNAPrint Genomics Benchmark Summation

DNAPrint Genomics Notable Stakeholders

The success or failure of an entity such as DNAPrint Genomics often depends on how effective the management is. DNAPrint Genomics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DNAPrint management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DNAPrint management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running DNAPrint Genomics' price analysis, check to measure DNAPrint Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNAPrint Genomics is operating at the current time. Most of DNAPrint Genomics' value examination focuses on studying past and present price action to predict the probability of DNAPrint Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNAPrint Genomics' price. Additionally, you may evaluate how the addition of DNAPrint Genomics to your portfolios can decrease your overall portfolio volatility.